Literature DB >> 32319570

Involvement of SAMHD1 in dNTP homeostasis and the maintenance of genomic integrity and oncotherapy (Review).

Zhou Zhang1, Lixia Zheng1, Yang Yu1, Jinying Wu1, Fan Yang1, Yingxi Xu1, Qiqiang Guo1, Xuan Wu1, Sunrun Cao1, Liu Cao1, Xiaoyu Song1.   

Abstract

Sterile alpha motif and histidine/aspartic acid domain‑containing protein 1 (SAMHD1), the only deoxynucleotide triphosphate (dNTP) hydrolase in eukaryotes, plays a crucial role in regulating the dynamic balance and ratio of cellular dNTP pools. Furthermore, SAMHD1 has been reported to be involved in the pathological process of several diseases. Homozygous SAMHD1 mutations have been identified in immune system disorders, such as autoimmune disease Aicardi‑Goutières syndrome (AGS), whose primary pathogenesis is associated with the abnormal accumulation and disproportion of dNTPs. SAMHD1 is also considered to be an intrinsic virus‑restriction factor by suppressing the viral infection process, including reverse transcription, replication, packaging and transmission. In addition, SAMHD1 has been shown to promote genome integrity during homologous recombination following DNA damage, thus being considered a promising candidate for oncotherapy applications. The present review summarizes the molecular mechanisms of SAMHD1 regarding the regulation of dNTP homeostasis and DNA damage response. Additionally, its potential effects on tumorigenesis and oncotherapy are reported.

Entities:  

Year:  2020        PMID: 32319570     DOI: 10.3892/ijo.2020.4988

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.

Authors:  Yifu Liu; Zhicheng Zhang; Shengqiang Fu; Siyuan Wang; Xiaofeng Cheng; Kunyang Lei; Zhilong Li; Ting Sun; Ming Ma
Journal:  Int J Gen Med       Date:  2021-10-13

2.  Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.

Authors:  Eudald Felip; Lucía Gutiérrez-Chamorro; Maica Gómez; Edurne Garcia-Vidal; Margarita Romeo; Teresa Morán; Laura Layos; Laia Pérez-Roca; Eva Riveira-Muñoz; Bonaventura Clotet; Pedro Luis Fernandez; Ricard Mesía; Anna Martínez-Cardús; Ester Ballana; Mireia Margelí
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

3.  Expression of SAMHD1 and its mutation on prognosis of colon cancer.

Authors:  Zhou Zhang; Ping Li; Ping Sun
Journal:  Oncol Lett       Date:  2022-07-08       Impact factor: 3.111

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.